Mechanisms of beta-cell failure in diabetes
Mechanisms of beta-cell failure in diabetes
批准号:
nhmrc : 427616
负责人:
A/Pr David Laybutt
金额:
$35.81万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2009-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The current epidemic of type 2 diabetes represents a major global health problem, with over 7% of the Australians suffering the disease. While there is a well-established relationship between obesity and insulin resistance, the majority of overweight individuals do not develop type 2 diabetes because their pancreatic beta-cells compensate with enhanced insulin secretion. It is the failure of beta-cell compensation that is fundamental to the development of diabetes. The beta-cell is a highly specialised cell with a unique metabolic profile and differentiation specifically geared towards making these cells able to sense fluctuations in circulating glucose levels and secrete insulin accordingly. We propose that in susceptible individuals, a gradual rise in blood glucose (hyperglycaemia) and lipid levels resulting from increasing obesity and insulin resistance leads to a loss of the unique expression pattern of genes necessary for appropriate insulin secretion. This exacerbates hyperglycaemia, which causes further beta-cell dedifferentiation and eventually the death of beta-cells by apoptosis. We have recently found evidence in several models of diabetes that supports this hypothesis. We propose to use animal studies and cell culture systems to investigate the following hypotheses important for our understanding of beta-cell failure and progression to diabetes: 1) The loss of beta-cell phenotype (dedifferentiation) underlies the loss of insulin secretory function in failing beta-cells. 2) Hyperglycaemia plays a critical role regulating the progression to beta-cell dedifferentiation. 3) The overexpression of key candidate gene products play an integral role linking hyperglycaemia to the loss of beta-cell secretion. 4) Endoplasmic reticulum stress is necessary for beta-cell death in diabetes. Our studies will make a major contribution to our understanding of why beta-cells fail in diabetes and aim to provide novel therapeutic targets in the treatment of diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New molecular mechanisms of islet protection against diabetes
-
批准号:nhmrc : 1144206
-
项目类别:Project Grants
-
资助金额:$45.52万
-
财政年份:2018
-
负责人:A/Pr David Laybutt
-
依托单位:
New molecular mechanisms of islet protection against diabetes
-
批准号:nhmrc : GNT1144206
-
项目类别:Project Grants
-
资助金额:$67.33万
-
财政年份:2018
-
负责人:A/Pr David Laybutt
-
依托单位:
Control of insulin secretion by Y1 receptor signalling
-
批准号:nhmrc : 1144286
-
项目类别:Project Grants
-
资助金额:$45.68万
-
财政年份:2018
-
负责人:A/Pr David Laybutt
-
依托单位:
Control of insulin secretion by Y1 receptor signalling
-
批准号:nhmrc : GNT1144286
-
项目类别:Project Grants
-
资助金额:$67.56万
-
财政年份:2018
-
负责人:A/Pr David Laybutt
-
依托单位:
Role of the adaptive unfolded protein response in beta-cell compensation
-
批准号:nhmrc : 1069511
-
项目类别:Project Grants
-
资助金额:$38.79万
-
财政年份:2014
-
负责人:A/Pr David Laybutt
-
依托单位:
Mechanisms of beta-cell compensation
-
批准号:nhmrc : GNT1069511
-
项目类别:Project Grants
-
资助金额:$56.26万
-
财政年份:2014
-
负责人:A/Pr David Laybutt
-
依托单位:
Mechanisms of beta-cell dysfunction in diabetes
-
批准号:nhmrc : 1030715
-
项目类别:Project Grants
-
资助金额:$47.61万
-
财政年份:2012
-
负责人:A/Pr David Laybutt
-
依托单位:
Beta cell mass in Type 1 diabetes mellitus and islet transplantation
-
批准号:nhmrc : 427695
-
项目类别:NHMRC Strategic Awards
-
资助金额:$204.72万
-
财政年份:2008
-
负责人:A/Pr David Laybutt
-
依托单位:
Mechanisms of fatty-acid mediated destruction of pancreatic beta cells
-
批准号:nhmrc : 376020
-
项目类别:NHMRC Project Grants
-
资助金额:$34.04万
-
财政年份:2006
-
负责人:A/Pr David Laybutt
-
依托单位:
Pancreatic beta-cell dysfunction in diabetes
-
批准号:nhmrc : 325618
-
项目类别:NHMRC Project Grants
-
资助金额:$25.96万
-
财政年份:2005
-
负责人:A/Pr David Laybutt
-
依托单位:
Islet B-cell growth, differentiation and function in typpw 2 diabetes:
-
批准号:nhmrc : 188829
-
项目类别:Career Development Fellowships
-
资助金额:$28.34万
-
财政年份:2002
-
负责人:A/Pr David Laybutt
-
依托单位:
国内基金
海外基金
登录
查看更多内容
人附睾蛋白4靶向调控TGF beta-smad轴加剧克罗恩病相关肠纤维化进程的作用机制研究
-
批准号:2026JJ82059
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吴一中
-
依托单位:
AAV介导sTGF-betaRII抑制TGF-beta/Smad2/3信号通路的抗口腔黏膜下纤维化基因治疗研究
-
批准号:JCZRLH202600804
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
AP2B通过WNT/BETA-CATENIN调控颅骨元件成骨活性差异的 分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:孙贤杰
-
依托单位:
TGF-beta通路通过降低自噬-基因组稳定性介导胶质母细胞瘤间质亚型替莫唑胺耐药的机制研究
-
批准号:82303919
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈鹭跃
-
依托单位:
一株新型野生动物来源Beta冠状病毒鉴定及感染人机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:史卫峰
-
依托单位:
多尺度增强航空用近beta钛合金的微观结构调控及疲劳性能研究
-
批准号:2023JJ40032
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:陈维
-
依托单位:
RNA结合蛋白Fam172a调控胰岛beta细胞胰岛素合成的作用与机制研究
-
批准号:82300891
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:徐捷
-
依托单位:
BRD4通过结合TEAD1调控β细胞增殖分化的机制研究
-
批准号:82370801
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李峰
-
依托单位:
碱性Beta分子筛封装CoOx及其HMF无碱氧化合成FDCA的性能研究
-
批准号:22368023
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:王宝荣
-
依托单位:
广义beta展式中若干问题研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:邹玉茹
-
依托单位: